To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36858618.
- Also identified by DOI 10.3949/ccjm.90a.22071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An initial bone mineral density (BMD) measurement is used to diagnose osteoporosis and decide whether patients need treatment, but the utility of repeating this test in those on treatment or on a drug holiday (ie, during a pause in bisphosphonate treatment) is controversial. Here, we present evidence for and against the use of BMD monitoring in patients receiving antiresorptive therapy or on a drug holiday, and give our recommendations, arguing against a one-size-fits-all approach.
Medical subject headings
- Bone Density
- Osteoporosis